<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the mechanism of Yishen Shengxue Tablet (YSSXT) in treating <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Observing the effect of YSSXT on hematopoietic, immunologic, anti-<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and body resistance of model mice of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: YSSXT had marked effect of promotion on recovering myleran injury induced reduction of colony forming unit-spleen (CFU-S), colony forming unit-culture (CFU-C), colony forming unit-erythrocyte (CFU-E), markedly promoting the peritoneal macrophage phagocytosis of <z:mpath ids='MPATH_458'>normal</z:mpath> mice, also markedly lower the mortality of Staphylococcus aureus inoculated mice, and elevate the <z:mp ids='MP_0002316'>anoxia</z:mp> resistant ability under <z:mpath ids='MPATH_458'>normal</z:mpath> pressure of anoxic mice, prolonging their survival time </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: Using YSSXT to treat <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> that the effectiveness might be realized through promoting the proliferation of hematopoietic stem cells of bone marrow, enhancing the non-specific immunity, and the anti-<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> as well as body resistance </plain></SENT>
</text></document>